These data suggest that MR signaling is detrimental for all cardiac parameters in nondiabetic hearts during ischemia as well as reperfusion phases, whereas in the diabetic hearts, at least for Pmax⁡, it may be detrimental only during the ischemia-induced phase of I/R injury. The gene discussed is NR3C2; the disease is ischemia.